Evidence map›Paper›PMID 31813124›Full record

ReviewMolecular neurobiology2020

Switching Operation Modes in the Neocortex via Cholinergic Neuromodulation : A Computational Model of Uncertainty, Learning, and Inhibition.

J-Y Puigbò, X D Arsiwalla, M A González-Ballester, P F M J Verschure

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Aging, uncertainty, and decision making-A review.Cognitive, affective & behavioral neuroscience · 2023
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J-Y PuigbòUniversitat Pompeu Fabra, Barcelona, Spain.
X D ArsiwallaUniversitat Pompeu Fabra, Barcelona, Spain.ORCID http://orcid.org/0000-0003-1485-1853
M A González-BallesterUniversitat Pompeu Fabra, Barcelona, Spain.
P F M J VerschureCatalan Institute of Bioengineering, Barcelona, Spain. pverschure@ibecbarcelona.eu.ORCID http://orcid.org/0000-0003-3643-9544

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to deal with the uncertainty in the world, our brains need to be able to flexibly switch between the exploration of new sensory representations and exploitation of previously acquired ones. This requires forming accurate estimations of what and how much something is expected. While modeling has allowed for the development of several ways to form predictions, how the brain could implement those is still under debate. Here, we recognize acetylcholine as one of the main neuromodulators driving learning based on uncertainty, promoting the exploration of new sensory representations. We identify its interactions with cortical inhibitory interneurons and derive a biophysically grounded computational model able to capture and learn from uncertainty. This model allows us to understand inhibition beyond gain control by suggesting that different interneuron subtypes either encode predictions or estimate their uncertainty, facilitating detection of unexpected cues. Moreover, we show how acetylcholine-like neuromodulation uniquely interacts with global and local sources of inhibition, disrupting perceptual certainty and promoting the rapid acquisition of new perceptual cues. Altogether, our model proposes that cortical acetylcholine favors sensory exploration over exploitation in a cortical microcircuit dedicated to estimating sensory uncertainty.

Indexed as

AcetylcholineAnimalsCholinergic AgentsComputer SimulationHumansInterneuronsNeocortexUncertaintyAcetylcholineCholinergic AgentsInhibitionLearningMicrocircuitryNeocortexNeuromodulationUncertainty

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.